Search

Your search keyword '"Villena, Teresa"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Villena, Teresa" Remove constraint Author: "Villena, Teresa"
39 results on '"Villena, Teresa"'

Search Results

1. Robust, fully-automated assessment of cerebral perivascular spaces and white matter lesions: a multicentre MRI longitudinal study of their evolution and association with risk of dementia and accelerated brain atrophy

2. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

3. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

4. Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

5. 18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

6. Type 2 diabetes mellitus, brain atrophy, and cognitive decline

7. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

8. Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density

9. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

10. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

11. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

12. The genetic architecture of the human cerebral cortex

13. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease

14. In vivo staging of regional amyloid deposition

15. Performance of [F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

16. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load

17. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

18. Identification of common variants associated with human hippocampal and intracranial volumes

19. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

20. Common genetic variants influence human subcortical brain structures

21. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

22. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes

23. Applying automated MR-based diagnostic methods to the memory clinic: A prospective study

24. Performance of [ 18 F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

25. Predicting missing biomarker data in a longitudinal study of Alzheimer disease

26. Vascular burden and Alzheimer disease pathologic progression

27. Sex-dependent association of common variants of microcephaly genes with brain structure

28. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

29. Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

30. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology

31. A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

32. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

33. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

34. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

35. Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

36. Hexanucleotide repeat expansions in C9ORF72in the spectrum of motor neuron diseases

37. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly

38. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease

39. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Catalog

Books, media, physical & digital resources